(Q79755662)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010292%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

FISH analysis of BRCA1 copy number in paraffin-embedded ovarian cancer tissue samples (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010292%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

Hisanori Kato

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010292%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Atsushi Arakawa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010292%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Kaoru Suzumori

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010292%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Nobuhiko Kataoka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010292%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

S Robert Young

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010292%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 April 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010292%20AND%20SRC:MED&resulttype=core&format=json

Experimental and Molecular Pathology

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010292%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010292%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010292%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

138-142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010292%20AND%20SRC:MED&resulttype=core&format=json

Risk models for familial ovarian and breast cancer

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Molecular cytogenetic mapping of 24 CEPH YACs and 24 gene-specific large insert probes to chromosome 17

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Comparative analysis of histologic homologues of endometrial and ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Comparison of alterations of chromosome 17 in carcinoma of the ovary and of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

BRCA1 and BRCA2 gene mutations and risk of breast cancer. Public health perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Chromosome 13 restriction fragment length polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Testing for Hereditary Risk of Ovarian Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Linkage of early-onset familial breast cancer to chromosome 17q21

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Detection of retinoblastoma gene copy number in metaphase chromosomes and interphase nuclei by fluorescence in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Mutation and cancer: statistical study of retinoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

The breast surgeon's role in BRCA1 and BRCA2 testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Loss of heterozygosity of BRCA1, TP53 and TCRD markers analysed in sporadic endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Loss of heterozygosity analysis at theBRCAloci in tumor samples from patients with familial breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Loss of heterozygosity on chromosome 17q11-21 in cancers of women who have both breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

7 January 2021

Tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

BRCA1 and BRCA2 and the genetics of breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.11.005

10.1016/J.YEXMP.2003.11.005

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15010292%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference